Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/26/1999 | CA2321482A1 Treating cancer |
08/26/1999 | CA2321481A1 Treating cancer |
08/26/1999 | CA2321480A1 Treating cancer |
08/26/1999 | CA2321479A1 Treating cancer |
08/26/1999 | CA2321467A1 Treating cancer |
08/26/1999 | CA2321458A1 Treating cancer |
08/26/1999 | CA2321438A1 Treating cancer |
08/26/1999 | CA2321264A1 Method for producing biotin |
08/26/1999 | CA2321262A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor |
08/26/1999 | CA2321224A1 Phosphodiesterase 10 |
08/26/1999 | CA2321222A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses |
08/26/1999 | CA2321199A1 Compositions and methods for regulating lymphocyte activation |
08/26/1999 | CA2321196A1 Recombinant active human zona pellucida protein 3 (hzp3) |
08/26/1999 | CA2321186A1 Apoptosis inducing molecule ii and methods of use |
08/26/1999 | CA2321184A1 Methods for designing inhibitors of serine/threonine kinases and tyrosine kinases |
08/26/1999 | CA2321180A1 Isolated and purified nucleic acids comprising a gene specifically expressed in hop glands |
08/26/1999 | CA2321176A1 Connective tissue growth factor homologs |
08/26/1999 | CA2321165A1 Antibodies against human cd40 |
08/26/1999 | CA2321140A1 Inhibitors of complement activation |
08/26/1999 | CA2321138A1 Methods for modulating seeds mass by expression of a nucleic acid containing an ap2 domain |
08/26/1999 | CA2321111A1 One-dimensional compound arrays and a method for assaying them |
08/26/1999 | CA2321106A1 Group b streptococcus antigens |
08/26/1999 | CA2321101A1 Modified heat shock protein-antigenic peptide complex |
08/26/1999 | CA2321088A1 Method for designing dna-binding proteins of the zinc-finger class |
08/26/1999 | CA2320808A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
08/26/1999 | CA2320801A1 Insecticidal toxins from photorhabdus |
08/26/1999 | CA2320799A1 Secreted proteins and polynucleotides encoding them |
08/26/1999 | CA2320759A1 Alkaline bacillus amylase |
08/26/1999 | CA2320632A1 Caf1-related protein |
08/26/1999 | CA2319132A1 Detection of wheat and barley fungal pathogens using the polymerase chain reaction |
08/26/1999 | CA2319079A1 Pollen specific promoter |
08/26/1999 | CA2319039A1 Biotin-binding receptor molecules |
08/26/1999 | CA2318811A1 Modulation of cell proliferation, methods and reagents |
08/26/1999 | CA2317922A1 Exo1 and exo2, exocytotic proteins |
08/26/1999 | CA2311649A1 Method for producing trifluoro-3(r)-hydroxybutyric acid derivatives |
08/25/1999 | EP0937780A1 Method for reducing inhibitors of nucleic acid hybridization |
08/25/1999 | EP0937777A2 GABA receptors and their uses |
08/25/1999 | EP0937775A2 Beta 1,3-N-acetylglucosaminyltransferase, DNA encoding it and its use |
08/25/1999 | EP0937773A2 Process for the preparation of enzymes and enzyme complexes |
08/25/1999 | EP0937256A2 Method and apparatus for collecting a cell sample from a liquid specimen |
08/25/1999 | EP0937157A1 Hydrolase binding assay |
08/25/1999 | EP0937156A2 Preparation of d-amino acids by direct fermentative means |
08/25/1999 | EP0937155A2 Resistance against nematodes and/or aphids |
08/25/1999 | EP0937154A2 Chimera gene with several herbicide resistant genes, plant cell and plant resistant to several herbicides |
08/25/1999 | EP0937153A1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
08/25/1999 | EP0937152A2 Screening for and use of an esterase for a stereospecific resolution |
08/25/1999 | EP0937151A1 Hepatitis c surrogate virus for testing the activity of hepatitis c virus protease, a recombinant gene and a use thereof |
08/25/1999 | EP0937150A2 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
08/25/1999 | EP0937149A2 Glucuronide repressors and uses thereof |
08/25/1999 | EP0937148A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
08/25/1999 | EP0937147A1 Human natural killer cell activating factor ii |
08/25/1999 | EP0937146A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
08/25/1999 | EP0937145A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis |
08/25/1999 | EP0937144A1 Human eosinophil-derived basic protein |
08/25/1999 | EP0937143A2 Secreted proteins and polynucleotides encoding them |
08/25/1999 | EP0937142A2 Secreted proteins and polynucleotides encoding them |
08/25/1999 | EP0937141A1 Polynucleotides encoding secreted proteins from human dendritic cells |
08/25/1999 | EP0937140A2 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
08/25/1999 | EP0937139A1 Amidase |
08/25/1999 | EP0937138A1 Cellulase variants |
08/25/1999 | EP0937137A1 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses |
08/25/1999 | EP0937104A1 Endothelium specific expression regulated by epcr control elements |
08/25/1999 | EP0937102A1 Human monocyte chemotactic proprotein |
08/25/1999 | EP0937099A1 Oligomers which inhibit the expression of interleukin genes |
08/25/1999 | EP0937098A1 Recombinational cloning using engineered recombination sites |
08/25/1999 | EP0937097A1 Compositions and methods for immobilizing nucleic acids to solid supports |
08/25/1999 | EP0937096A2 High density immobilization of nucleic acids |
08/25/1999 | EP0937095A1 Targeted cytolysis of cancer cells |
08/25/1999 | EP0937090A1 Methods for labeling nucleotides, labeled nucleotides and useful intermediates |
08/25/1999 | EP0936922A1 Polynucleotide vaccine formula for treating horse diseases |
08/25/1999 | EP0936920A1 NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS |
08/25/1999 | EP0936919A2 VARIANTS OF HUMAN CILIARY NEUROTROPHIC FACTOR (hCNTF) WITH A RANGE OF ACTION DIFFERENT FROM THAT OF THE WILD-TYPE MOLECULE |
08/25/1999 | EP0804566A4 Blue light photoreceptors and methods of using the same |
08/25/1999 | EP0804457A4 Modified green fluorescenct proteins |
08/25/1999 | EP0783482A4 Cationic transport reagents |
08/25/1999 | EP0765111B1 Starch and milled grain with a novel genotype |
08/25/1999 | EP0682706B1 Novel compounds |
08/25/1999 | EP0667858B1 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists |
08/25/1999 | EP0592566B1 Cysteine depleted il-6 muteins |
08/25/1999 | EP0237545B2 Production of pluripotent granulocyte colony-stimulating factor |
08/25/1999 | CN1226932A Process for inactivation of genes which code for enzymes for catabolism of phenyl acetate, plasmids involved in such process and strains transformed therewith |
08/25/1999 | CN1226931A Escherichia coli strains and preparation thereof and use thereof in fermentation process for production of L-threonine |
08/25/1999 | CN1226930A Antisense base sequences |
08/25/1999 | CN1226929A Valtage-gated calcium channel antagonist and methods |
08/25/1999 | CN1226928A Probe foranalysis of nucleic acids |
08/25/1999 | CN1226926A Plasminogen Activator capable of being activated by thrombin |
08/25/1999 | CN1226925A Phosphate starvation-inducible proteins |
08/25/1999 | CN1226896A Modulating activity of hormones or their receptors-peptides, antibodies, vaccines and uses thereof |
08/25/1999 | CN1226835A -i gene transfer methods for wound healing |
08/25/1999 | CN1226829A Method for treating gastrointestinal damage |
08/25/1999 | CN1226600A Reagent box for extracting DNA fast and use thereof |
08/24/1999 | US5942664 Isolated mutant bacillus thuringiensis cry1c delta-endotoxin polypeptide having improved insecticidal activity |
08/24/1999 | US5942663 Transformed biological protein |
08/24/1999 | US5942662 Inducible herbicide resistance |
08/24/1999 | US5942661 Transformation of crop susceptible to mycotoxin contamination under the regulation of operable promoter with gene encoding lipoxygenase pathway enzyme that produces 13-hydroperoxy linoleic acid sufficient to inhibit mycotoxin production |
08/24/1999 | US5942660 A plant having a genome of recombinant dna encoding increased levels of beta-ketothiolase, a beta-ketoacyl-coenzyme a reductase, a polyhydroxyalkanate symthase and a deregulated threonine deaminase |
08/24/1999 | US5942659 Producing transgenic oleaginous plant having lipase gene coding for lipase enzyme; collecting seeds or fruits; crushing seeds or fruits with lipids; incubating to effect enzymatic hydrolysis; extracting fatty acids |
08/24/1999 | US5942658 Genetic engineering |
08/24/1999 | US5942657 Inhibition of polygalacturonase and pectin esterase in a tomato plant by introducing into the plant a single control gene having dna regions homologous to the tomato genes and a promoter operative in tomato plants adapted to transcription |
08/24/1999 | US5942609 Annealing immobilized assembly oligonucleotide, other assembly oligonucleotides, and bridging oligonucleotides; ligating nick sites; annealing primer to product; chain extension of primer creating double stranded polynucleotide |